These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3045745)

  • 21. [Monocyte chemotaxis: critical evaluation of 2 methods of quantification].
    Jiménez López A; Olmos Martínez JM; García Palomo JD; Sánchez Hernández JJ; De Dios Martín B; Pedraz García MJ
    Allergol Immunopathol (Madr); 1984; 12(2):123-8. PubMed ID: 6380248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis. Chemotaxis, phagocytosis and opsonized effect of PSS sera on normal granulocytes.
    Sipos A; Czirják L; Lörincz G; Szegedi G
    Scand J Rheumatol; 1988; 17(1):43-50. PubMed ID: 3368751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
    J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytosis-associated functions in neonatal monocyte-derived macrophages.
    Speer CP; Gahr M; Wieland M; Eber S
    Pediatr Res; 1988 Aug; 24(2):213-6. PubMed ID: 2847109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective activity of monocytes from patients with non-Hodgkin lymphoma. The modulatory effect of granulocyte-macrophage-colony stimulating factor.
    Burgaleta C; Villalba S; González N
    Cancer; 1999 Nov; 86(10):2133-7. PubMed ID: 10570442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes.
    Cosio FG
    J Lab Clin Med; 1984 Apr; 103(4):613-9. PubMed ID: 6699476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of killed Mycobacterium leprae and other mycobacteria on opsonized yeast phagocytosis.
    Cree IA; Beck JS
    Clin Exp Immunol; 1986 Apr; 64(1):35-40. PubMed ID: 3524918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.
    Stuart JM; Postlethwaite AE; Kang AH
    J Lab Clin Med; 1976 Oct; 88(4):601-7. PubMed ID: 965811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
    Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
    Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood monocyte function in leprosy patients.
    Masuda A; Scheinberg MA
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):254-9. PubMed ID: 7192267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease.
    Nielsen H; Bonde J
    Eur J Respir Dis; 1986 Mar; 68(3):200-6. PubMed ID: 3516718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific suppressor cell activity in patients with scleroderma.
    Keystone EC; Gladman DD; Baron M; Cane D; Poplonski L
    J Rheumatol; 1981; 8(5):747-51. PubMed ID: 6171643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).
    Tai PC; Spry CJ
    Clin Exp Immunol; 1980 Apr; 40(1):206-19. PubMed ID: 6993078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-1-antitrypsin-induced inhibition of complement-dependent phagocytosis.
    Mód A; Füst G; Gergely J; Hollán SR; Dierich MP
    Immunobiology; 1981; 158(4):338-46. PubMed ID: 7016739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphonuclear neutrophil function in systemic sclerosis.
    Czirják L; Dankó K; Sipka S; Zeher M; Szegedi G
    Ann Rheum Dis; 1987 Apr; 46(4):302-6. PubMed ID: 3592786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative and qualitative study of blood monocytes in smokers.
    Nielsen H
    Eur J Respir Dis; 1985 May; 66(5):327-32. PubMed ID: 3894043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial characterization of phagocytic activity in neutrophils of the nine-banded armadillo Dasypus novemcinctus.
    López-Hurtado M; Flores-Medina S; Díaz-García FJ; Guerra-Infante FM
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):269-75. PubMed ID: 15913787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1989 Feb; 142(3):959-65. PubMed ID: 2643666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.